AQST(Aquestive Therapeutics, Inc.) · 财务报表

AQST(Aquestive Therapeutics, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$50.83M$47.68M$50.58M$57.56M$44.55M
毛利润—$28.29M$29.75M$39.69M$25.99M
营业利润−$34.68M−$42.07M−$15.10M−$30.77M−$71.05M
净利润−$70.54M−$54.41M−$7.87M−$44.14M−$83.78M
经营现金流−$32.98M−$9.82M−$6.38M−$35.76M−$52.43M
自由现金流−$33.89M−$10.84M−$7.38M−$35.92M−$52.99M
摊薄每股收益$-1.85$-1.12$-0.13$-0.51$-0.78

Aquestive Therapeutics, Inc. AQST